ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Learning Cognitive-Test-Based Interpretable Rules for Prediction and Early Diagnosis of Dementia Using Neural Networks

Wang, Zhuo; Wang, Jie; Liu, Ning; Liu, Caiyan; Li, Xiuxing; Dong, Liling; Zhang, Rui; Mao, Chenhui; Duan, Zhichao; Zhang, Wei; Gao, Jing*; Wang, Jianyong*清华大学; 中国医学科学院; 中国医学科学院北京协和医院; 1
JOURNAL OF ALZHEIMERS DISEASE2022DOI: 10.3233/JAD-220502
1被引8阅读
引用收藏
分享

摘要

Background: Accurate, cheap, and easy to promote methods for dementia prediction and early diagnosis are urgently needed in low- and middle-income countries. Integrating various cognitive tests using machine learning provides promising solutions. However, most effective machine learning models are black-box models that are hard to understand for doctors and could hide potential biases and risks. @@@ Objective: To apply cognitive-test-based machine learning models in practical dementia prediction and diagnosis by ensuring both interpretability and accuracy. @@@ Methods: We design a framework adopting Rule-based Representation Learner (RRL) to build interpretable diagnostic rules based on the cognitive tests selected by doctors. According to the visualization and test results, doctors can easily select the final rules after analysis and trade-off. Our framework is verified on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset (n = 606) and Peking Union Medical College Hospital (PUMCH) dataset (n = 375). @@@ Results: The predictive or diagnostic rules learned byRRLoffer a better trade-off between accuracy and model interpretability than other representative machine learning models. For mild cognitive impairment (MCI) conversion prediction, the cognitivetest-based rules achieve an average area under the curve (AUC) of 0.904 on ADNI. For dementia diagnosis on subjects with a normal Mini-Mental State Exam (MMSE) score, the learned rules achieve an AUC of 0.863 on PUMCH. The visualization analyses also verify the good interpretability of the learned rules. @@@ Conclusion: With the help of doctors and RRL, we can obtain predictive and diagnostic rules for dementia with high accuracy and good interpretability even if only cognitive tests are used.

学科与关键词

关键词
Deep learningdementiainterpretabilitymachine learningneuropsychological tests
相关
加载中…
  • Random Forest Model in the Diagnosis of Dementia Patients with Normal Mini-Mental State Examination Scores
    Wang, Jie; Wang, Zhuo; Liu, Ning; Liu, Caiyan; Mao, Chenhui; Dong, Liling; Li, Jie; Huang, Xinying; Lei, Dan; Chu, Shanshan; Wang, Jianyong*; Gao, Jing*Journal of Personalized Medicine, 2022, 12(1): 37.被引 12
  • Develop a diagnostic tool for dementia using machine learning and non-imaging features
    Wang, Huan; Sheng, Li; Xu, Shanhu; Jin, Yu; Jin, Xiaoqing; Qiao, Song; Chen, Qingqing; Xing, Wenmin; Zhao, Zhenlei; Yan, Jing*; Mao, Genxiang*; Xu, Xiaogang*Frontiers in Aging Neuroscience, 2022, 14: 945274.被引 5
  • A dominant set-informed interpretable fuzzy system for automated diagnosis of dementia
    Chen, Tianhua*; Su, Pan; Shen, Yinghua; Chen, Lu; Mahmud, Mufti; Zhao, Yitian; Antoniou, GrigorisFrontiers in Neuroscience, 2022, 16: 867664.被引 23
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF ALZHEIMERS DISEASE
发表日期
2022
卷期
第 90 卷, 第 2 期
页码
609-624
DOI
10.3233/JAD-220502
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2020YFA0804503, 2020YFA0804501]; National Natural Science Foundation of China [61521002]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Beijing Academy of Artificial Intelligence (BAAI); AbbVie; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research

作者

  • W

    Wang, Zhuo (第一作者)

    tsinghua univ

  • W

    Wang, Jie

    1 · chinese acad med sci · peking union med coll · peking union med coll hosp

查看全部 12 位作者收起作者
  • L

    Liu, Ning

    tsinghua univ

  • L

    Liu, Caiyan

    1 · chinese acad med sci · peking union med coll · peking union med coll hosp

  • L

    Li, Xiuxing

    tsinghua univ

  • D

    Dong, Liling

    1 · chinese acad med sci · peking union med coll · peking union med coll hosp

  • Z

    Zhang, Rui

    tsinghua univ

  • M

    Mao, Chenhui

    1 · chinese acad med sci · peking union med coll · peking union med coll hosp

  • D

    Duan, Zhichao

    tsinghua univ

  • Z

    Zhang, Wei

  • G

    Gao, Jing (通讯)

    1 · chinese acad med sci · peking union med coll · peking union med coll hosp

  • W

    Wang, Jianyong (通讯)

    tsinghua univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417